Bionic Eye Market Latest Study (Retina Implant AG, Bionic Vision Australia, NeoStrata) with Competitive Landscape by 2023

“Bionic Eye Market”
Bionic Eye Market Research Report, By Types (External Eye and Implanted Eye), By Technology, By End Users – Forecast Till 2023

Global Bionic Eye Market is growing at a CAGR of 9.8% during forecasted period 2017-2023. 

Bionic eye is a computer chip that is placed in the back of the eye. These devices are used to treat the blindness in the people. Global bionic eye market is growing at a swift rate. Continuous increasing demand for the bionic eye and increasing number of visually impaired people across the globe is the major driving factor for Bionic Eye Market. According to WHO, number of visually impaired patients is continuously rising and about 90% of these patients are living in developing countries. Increasing people having vitamin deficiency and increasing diseases related blindness is driving the growth of the market. Beside this increasing aging population across the globe is also contributed in the growth of market. While high cost and limited surgical professionals of the treatment can hamper the growth of the market.

Get a Sample Report @ .

Competitive Analysis

The major key player for the Global bionic eye market are Retina Implant AG (Germany), Second Sight (US), Bionic Vision Australia (Australia), The Bionic Eye (UK), Pixium Vision (France), iBionics (Canada), NeoStrata (US).

Due to increasing prevalence of diseases like diabetes in the world and increasing number of people suffering from vision loss has attracted man of the major and medium sized company to introduce the better for the treatment. Many company are investing in R&D so as to introduce a new device and method so as to withstand the competition and increase the market.

Retina Implant AG is the German headquartered company working in the manufacturing of the medical technologies. Retina Implant Alpha IMS is the most famous product of the company. In 2017, Okuvision and Retina Implant are merge together under the parent company Retina Implant AG.

Second Sight is the US headquarter company. The company has got FDA approval for the first visual prosthesis in 2013. Argus II Retinal Prosthesis System is the major product of the company. Argus II provides the electrical stimulation of the retina to induce visual perception in blind individuals.

Order Copy of 80 Premium Pages is Available @ .

Bionic Vision Australia is an Australian company. This company has introduced Suprachoroidal Retinal Prosthesis for the treatment of visual impairment. This treatment will provide vision to blind patients suffering from degenerative retinal conditions.

Pixium Vision is medical device manufacturing company headquartered in France. Intelligent Retinal Implant System is the major product of the company. IRIS is under clinical trials and PRIMA is under preclinical development.

NeoStrata is a professional skin care brand recommend by most the physicians worldwide. PHA 4 is the bionic eye cream manufactured by this company.

Brief TOC                                                                          

1      Introduction

2      Research Methodology    

3      Market Dynamics    

4      Market Factor Analysis    

5      Global Bionic Eye Market, By Type

6      Global Bionic Eye Market, By Technology

7      Global Bionic Eye Market, By End User

8      Global Bionic Eye Market, By Region

9      Competitive Landscape    

10   Company Profile    

11   Conclusion

12   Appendix

Ask to Expert @ .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India